Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

O-GlcNac Modified Proteomics Study of the Maturation of Hemodialysis Arteriovenous

NCT05832476 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT05832476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05832476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
O-GlcNac Modified Proteomics Study of the Maturation of Hemodialysis Arteriovenous
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Completed
Start date
March 28, 2018
Completion date
October 26, 2020
Enrollment
126 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arteriovenous fistula occlusion